Surgery Partners Stock Market Value
| SGRY Stock | USD 23.39 0.38 1.65% |
| Symbol | Surgery |
Surgery Partners Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 23.69 | Quarterly Revenue Growth 0.143 | Return On Assets 0.039 | Return On Equity 0.0308 |
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Surgery Partners 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Surgery Partners' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Surgery Partners.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Surgery Partners on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Surgery Partners or generate 0.0% return on investment in Surgery Partners over 30 days. Surgery Partners is related to or competes with Pennant, Ensign, Encompass Health, Healthcare Services, Enhabit, InnovAge Holding, and National HealthCare. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary servi... More
Surgery Partners Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Surgery Partners' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Surgery Partners upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 31.36 | |||
| Value At Risk | (4.88) | |||
| Potential Upside | 3.73 |
Surgery Partners Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgery Partners' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Surgery Partners' standard deviation. In reality, there are many statistical measures that can use Surgery Partners historical prices to predict the future Surgery Partners' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.17) |
Surgery Partners Backtested Returns
Surgery Partners owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.15, which indicates the firm had a -0.15% return per unit of risk over the last 3 months. Surgery Partners exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Surgery Partners' Coefficient Of Variation of (1,381), risk adjusted performance of (0.05), and Variance of 13.46 to confirm the risk estimate we provide. The entity has a beta of 1.6, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Surgery Partners will likely underperform. At this point, Surgery Partners has a negative expected return of -0.45%. Please make sure to validate Surgery Partners' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and relative strength index , to decide if Surgery Partners performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Surgery Partners has virtually no predictability. Overlapping area represents the amount of predictability between Surgery Partners time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Surgery Partners price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Surgery Partners price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | -0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 8.72 |
Surgery Partners lagged returns against current returns
Autocorrelation, which is Surgery Partners stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Surgery Partners' stock expected returns. We can calculate the autocorrelation of Surgery Partners returns to help us make a trade decision. For example, suppose you find that Surgery Partners has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Surgery Partners regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Surgery Partners stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Surgery Partners stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Surgery Partners stock over time.
Current vs Lagged Prices |
| Timeline |
Surgery Partners Lagged Returns
When evaluating Surgery Partners' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Surgery Partners stock have on its future price. Surgery Partners autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Surgery Partners autocorrelation shows the relationship between Surgery Partners stock current value and its past values and can show if there is a momentum factor associated with investing in Surgery Partners.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.